Nvidia AI Server Prices Set to Rise as Memory Costs Surge 
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO 
REPAY Stock Rises After Visa Platform Connect Collaboration 
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead 
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits 
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks 
Barclays Downgrades Renault as Cost Savings Challenges Grow 
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised 
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme 
Hyundai Motor Union Launches First Full Strike in Decade Over Wages, AI Job Risks 
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut 
SpaceX Hires Natural Gas Trader to Meet Growing Energy Needs 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
Standard Chartered Expands Hedge Fund Access for Wealth Clients 
OpenAI Tightens AI Safety Monitoring After Security Incidents 
Coty Revenue Beats Estimates as Beauty Demand Holds Firm 
Add as a preferred source on Google
BUENA, N.J., May 07, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43rd Annual Health Care Conference. The Conference is taking place May 8-9, 2018 at the Intercontinental Hotel, Boston.
Damian Finio, Chief Financial Officer of Teligent, Inc., will present on Tuesday, May 8th at 2:10 p.m. ET.
The presentation will be webcast and accessible online via the investors section of the Company's website at www.teligent.com. A replay will be available for 30 days.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
Contact:
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com
